Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 1, 2011, Pages

  Cabrales, Pedro ^a   Han, George ^b   Nacharaju, Parimala ^b   Friedman, Adam J ^b   Friedman, Joel M ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Blood substitutes; Endothelial dysfunction; Gas delivery; Hemolysis; Hypertension; Nanotechnology; Transfusion medicine

Indexed keywords

HEMOGLOBIN; METHEMOGLOBIN; NANOPARTICLE; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTERY PERFUSION; ARTICLE; BLOOD GAS; CONTROLLED STUDY; HAMSTER; HEART RATE; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; CRICETINAE; HEART RATE; HEMOGLOBINS; MALE; MESOCRICETUS; MICROCIRCULATION; NANOPARTICLES; NITRIC OXIDE; RANDOM ALLOCATION; VASOCONSTRICTION;

EID: 78651292791     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00665.2010     Document Type: Article

References (44)

1. Alayash AI. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov 3: 152-159, 2004.
2. Amberson WR, Jennings JJ, Rhode CM. Clinical experience with hemoglobin-saline solutions. J Appl Physiol 1: 469-489, 1949.
3. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 34: 34-40, 1997.
4. Bunn HF, Esham WT, Bull RW. Renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 129: 909-&, 1969.
5. Cabrales P, Han G, Roche C, Nacharaju P, Friedman AJ, Friedman JM. Sustained release nitric oxide from long lived circulating nanoparticles. Free Rad Med Biol 49: 530-508, 2010.
6. Cabrales P, Tsai AG, Intaglietta M. Polymerized bovine hemoglobin can improve small-volume resuscitation from hemorrhagic shock in hamsters. Shock 31: 300-307, 2009.
7. Colantuoni A, Bertuglia S, Intaglietta M. Quantitation of rhythmic diameter changes in arterial microcirculation. Am J Physiol Heart Circ Physiol 246: H508-H517, 1984.
8. Endrich B, Asaishi K, Götz A, Messmer K. Technical report-a new chamber technique for microvascular studies in unanaesthetized hamsters. Res Exp Med 177: 125-134, 1980.
9. Finucane ML, Slovic P, Mertz CK. Public perception of the risk of blood transfusion. Transfusion 40: 1017-1022, 2000.
10. Freilich D, Pearce LB, Pitman A, Greenburg G, Berzins M, Bebris L, Ahlers S, McCarron R. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects- extrapolation of potential risk for acute trauma trials. J Trauma Injury Infect Crit Care 66: 365-376, 2009.
11. Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, Friedman JM. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 19: 12-20, 2008.
12. Gilligan DR, Altschule MD, Katersky EM. Studies of hemoglobinemia and hemoglobinuria produced in man by intravenous injection of hemoglobin solutions. J Clin Invest 20: 177-187, 1941.
13. Gori T, Parker JD. The puzzle of nitrate tolerance: pieces smaller than we thought? Circulation 106: 2404-2408, 2002.
14. Gotshall RW, Hamilton KL, Foreman B, van Patot MC, Irwin DC. Glutaraldehyde-polymerized bovine hemoglobin and phosphodiesterase-5 inhibition. Crit Care Med 37: 1988-1993, 2009.
15. Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, Moss GS. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 187: 112-120, 1998.
16. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, Intaglietta M, van der Heyde HC. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 12: 1417-1422, 2006.
17. Greenburg AG. Benefits and risks of blood transfusion in surgical patients. World J Surg 20: 1189-1193, 1996.
18. Greenburg AG, Kim HW. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. J Am Coll Surg 198: 373-384, 2004.
19. Guyton AC, Langston JB, Navar G. Theory for renal autoregulation by feedback at the juxtaglomerular apparatus. Circ Res Suppl 15: 187-197, 1964.
20. Homer K, Wanstall J. In vitro comparison of two NONOates (novel nitric oxide donors) on rat pulmonary arteries. Eur J Pharmacol 356: 49-57, 1998.
21. Intaglietta M, Silverman NR, Tompkins WR. Capillary flow velocity measurements in vivo and in situ by television methods. Microvasc Res 10: 165-179, 1975.
22. Intaglietta M, Tompkins WR. Microvascular measurements by video image shearing and splitting. Microvasc Res 5: 309-312, 1973.
23. Irwin D, Buehler PW, Alayash AI, Jia Y, Bonventura J, Foreman B, White M, Jacobs R, Piteo B, TissotvanPatot MC, Hamilton KL, Gotshall RW. Mixed S-nitrosylated polymerized bovine hemoglobin species moderate hemodynamic effects in acutely hypoxic rats. Am J Respir Cell Mol Biol 42: 200-209, 2010.
24. Katz LM, Manning JE, McCurdy S, Sproule C, McGwin G Jr, Moon-Massat P, Cairns CB, Freilich D. Nitroglycerin attenuates vasoconstriction of HBOC-201 during hemorrhagic shock resuscitation. Resuscitation 81: 481-487, 2010.
25. Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, Beavo JA, Berk BC, Yan C. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation 104: 2338-2343, 2001.
26. Lancaster JR. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91: 8137-8141, 1994.
27. Lancaster JR Jr. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1: 18-30, 1997.
28. Lipowsky HH, Zweifach BW. Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 15: 93-101, 1978.
29. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 70: 15-28, 2004.
30. Maton A, Hopkins J, McLaughlin CW, Johnson S, Warner MQ, LaHart D, Wright JD. Human Biology and Health. Englewood Cliffs, NJ: Prentice Hall, 1993.
31. Minneci PC, Deans KJ, Shiva S, Zhi H, Banks SM, Kern S, Natanson C, Solomon SB, Gladwin MT. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circ Physiol 295: H743-H754, 2008.
32. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, Solomon SB. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 115: 3409-3417, 2005.
33. Naumann HN, Diggs LW, Barreras L, Williams BJ. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am J Clin Pathol 56: 137-147, 1971.
34. Patel RP. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. Free Radic Biol Med 28: 1518-1525, 2000.
35. Qiu W, Kass DA, Hu Q, Ziegelstein RC. Determinants of shear stress-stimulated endothelial nitric oxide production assessed in real-time by 4,5-diaminofluorescein fluorescence. Biochem Biophys Res Commun 286: 328-335, 2001.
36. Reid TJ. Hb-based oxygen carriers: are we there yet? Transfusion 43: 280-287, 2003.
37. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO, 3rd Schechter AN, Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8: 1383-1389, 2002.
38. Rodriguez C, Vitturi DA, He J, Vandromme M, Brandon A, Hutchings A, Rue LW, 3rd Kerby JD, Patel RP. Sodium nitrite therapy attenuates the hypertensive effects of HBOC-201 via nitrite reduction. Biochem J 422: 423-432, 2009.
39. Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 67: 99-145, 2005.
40. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 49: 1S-235S, 2009.
41. Winterbourn CC. Reaction of superoxide with hemoglobin. In: CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC, 1985, p. 137-141.
42. Wittenberg JB. The molecular mechanism of hemoglobin-facilitated oxygen diffusion. J Biol Chem 241: 104-114, 1966.
43. Yu B, Raher MJ, Volpato GP, Bloch KD, Ichinose F, Zapol WM. Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 117: 1982-1990, 2008.
44. Yu B, Volpato GP, Chang K, Bloch KD, Zapol WM. Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide. Anesthesiology 110: 113-122, 2009.